EUR-Lex Search results

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Search Results

Query: ((BF = "32001L0083" AND DD = 01/01/2022) OR (RESOURCE_LEGAL_CORRECTS_RESOURCE_LEGAL = "32001L0083" AND DD >= 01/01/2022 AND DD < 27/05/2022 AND (EMBEDDED_ACT_CONSOLIDATED_DATE > 01/01/2022 OR EMBEDDED_ACT_CONSOLIDATED_DATE = NULL)) OR ((RESOURCE_LEGAL_REPEALS_RESOURCE_LEGAL = "32001L0083" OR RESOURCE_LEGAL_IMPLICITLY_REPEALS_RESOURCE_LEGAL = "32001L0083" OR RESOURCE_LEGAL_RENDERS_OBSOLETE_RESOURCE_LEGAL = "32001L0083" OR RESOURCE_LEGAL_REPLACES_RESOURCE_LEGAL = "32001L0083" OR RESOURCE_LEGAL_SUSPENDS_RESOURCE_LEGAL = "32001L0083" OR RESOURCE_LEGAL_PARTIALLY_SUSPENDS_RESOURCE_LEGAL = "32001L0083" OR RESOURCE_LEGAL_AMENDS_RESOURCE_LEGAL = "32001L0083") AND DD > 01/01/2022 AND DD <= 27/05/2022)) AND (EMBEDDED_WHE_EXPRESSION_LG=ENG), Search language: English

Directive (EU) 2022/642 of the European Parliament and of the Council of 12 April 2022 amending Directives 2001/20/EC and 2001/83/EC as regards derogations from certain obligations concerning certain medicinal products for human use made available in the United Kingdom in respect of Northern Ireland and in Cyprus, Ireland and Malta (Text with EEA relevance)

PE/6/2022/REV/1

In force

CELEX number:
32022L0642
Form:
Directive
Author:
European Parliament, Council of the European Union
Date of document:
12/04/2022; Date of signature